CrossRef Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension Jun Sung Moon, Kyung-Ah Han, Jae Myung Yu, Jong Chul Won, Jun Goo Kang, Soojin Park, Cheol-Young Park Diabetes Research and Clinical Practice.2026
L-Carnitine 6 12 1.2
She offered a checklist for consumers deciding whether to order the GLP-1 friendly item: Is there a meaningful protein source, not just a small amount
Its associated adverse effects include hepatotoxicity, nephrotoxicity, central nervous system (CNS) depression, respiratory failure, acute pancreatitis, thrombocytopenia, hyperammonaemia, bone marrow suppression, and teratogenicity